Results 151 to 160 of about 6,682 (198)

Autoantikörper gegen Annexin A5 [PDF]

, 2017
openaire   +1 more source

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. [PDF]

Nat Commun, 2020
Kang TH, Park JH, Yang A, Park HJ, Lee SE, Kim YS, Jang GY, Farmer E, Lam B, Park YM, Hung CF.   +10 more
europepmc   +1 more source

Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+ T cell immunity for tumor clearance. [PDF]

Cell Mol Immunol, 2021
Kang TH, Yang A, Tsai Y, Ferrall L, Hung CF.   +4 more
europepmc   +1 more source

Annexin-A5 is fundamental for VDAC1-dependent mitochondrial Ca2+ homeostasis and determines the susceptibility to apoptosis.

, 2023
Graier W, Oflaz F, Bondarenko A, Trenker M, Waldeck-Weiermair M, Gottschalk B, Bernhart E, Koshenov Z, Radulović S, Rost R, Hirtl M, Pilic J, Leitinger G, Brachvogel B, Summerauer S, Shoshan-Barmatz V, Malli R.   +16 more
europepmc   +1 more source

Augmentation of Nr4a3 and Suppression of Fshb Expression in the Pituitary Gland of Female Annexin A5 Null Mouse. [PDF]

J Endocr Soc, 2020
Terashima R, Saigo T, Laoharatchatathanin T, Kurusu S, Brachvogel B, Pöschl E, Kawaminami M.   +6 more
europepmc   +1 more source

Annexin A5 knockdown inhibits cardiomyocyte apoptosis and alleviates cardiac hypertrophy via activating the PI3K/AKT/Bcl-2 signaling pathway. [PDF]

Sci Rep
Zhao L, Cao H, Yuan Y, Liao C, Huang D, Li X, Zhao Y, Huang Q, Li S, Zhang B.   +9 more
europepmc   +1 more source

Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. [PDF]

Mol Biomed
Woodward A, Southard B, Chakraborty S, Bailey AO, Faria GNF, McKernan P, Razaq W, Harrison RG.   +7 more
europepmc   +1 more source

Annexin A5 Derived from Cell-free Fat Extract Attenuates Osteoarthritis via Macrophage Regulation. [PDF]

Int J Biol Sci
Jia Z, Kang B, Dong Y, Fan M, Li W, Zhang W.   +5 more
europepmc   +1 more source

Annexin-A5 Overexpression Increases Sensitivity of MCF-7 and MCF-7/ADR Cells to Epirubicin. [PDF]

Avicenna J Med Biotechnol
Ghasemi M, Reiazi N, Behzad-Behbahani A, Takhshid MA.   +3 more
europepmc   +1 more source

Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia. [PDF]

Ther Adv Med Oncol, 2020
Zhang N, Zhang Y, Zhang P, Lou S, Chen Y, Li H, Zeng H, Shen Y, Deng J.   +8 more
europepmc   +1 more source